Live non-attenuated transmissible vaccine
Vaccine production during pandemics encounters severe bottlenecks that give rise to the shortages many health departments dread. Chief among these bottlenecks is the availability of bioreactor organisms with sufficient capacity to produce this vital preventative medicine.